Combining epigenetic and immune checkpoint inhibitors in bladder cancer

被引：0
|
作者：
Clemens Thoma
机构：
[1] Nature Reviews Urology,
来源：
Nature Reviews Urology | 2019年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：507 / 507
相关论文
共 50 条
  • [41] Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
    Pan, Shen
    Zhan, Yunhong
    Chen, Xiaonan
    Wu, Bin
    Liu, Bitian
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [42] Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
    Long, Qilai
    Ma, Ai-Hong
    Zhang, Hongyong
    Cao, Zhixiu
    Xia, Roger
    Lin, Tzu-Yin
    Sonpavde, Guru P.
    White, Ralph de Vere
    Guo, Jianming
    Pan, Chong-Xian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (11) : 2305 - 2317
  • [43] To Evaluate the Effect of Immune Checkpoint Inhibitors on Bladder Cancer: Efficacy, Safety and Prognostic of Geriatrics
    Zhang, Chuan
    Wang, Hao
    Li, Yue
    Zhang, Li
    Wang, Kai
    Liu, Hao
    Hu, Fugui
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 9 - 10
  • [44] Effect of KDR mutations on efficacy of immune checkpoint inhibitors in patients with bladder cancer.
    Dai, Honghai
    Zhang, Qin
    Tan, Yuan
    Duan, Qianqian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
    Qilai Long
    Ai-Hong Ma
    Hongyong Zhang
    Zhixiu Cao
    Roger Xia
    Tzu-Yin Lin
    Guru P. Sonpavde
    Ralph de Vere White
    Jianming Guo
    Chong-Xian Pan
    Cancer Immunology, Immunotherapy, 2020, 69 : 2305 - 2317
  • [46] The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review
    Petzold, Aline Petracco
    Lubianca, Fernanda Nascimento
    Passos, Laura Gazal
    Keppler, Carolina Knorst
    Becker, Nicole Bernd
    Viera, Carolina de Mello
    Fay, Andre Poisl
    Carvalhal, Gustavo Franco
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [47] Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer
    Rhea, Logan P.
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [48] The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
    Tong, Huan
    Wei, He
    Smith, Alhaji Osman
    Huang, Juan
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [49] Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
    Ciciola, Paola
    Cascetta, Priscilla
    Bianco, Cataldo
    Formisano, Luigi
    Bianco, Roberto
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [50] Safety and Outcomes of Combining Immune Checkpoint Inhibitors with Radiation Therapy
    Mohamad, O.
    Leiker, A.
    Schroeder, S.
    Zhang, E.
    Trivedi, L.
    Gerber, D.
    Khan, S.
    Iyengar, P.
    Albuquerque, K. V.
    Arriaga, Y.
    Courtney, K.
    Brugarolas, J.
    Hammers, H.
    Timmerman, R. D.
    Hannan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E610 - E611
12345